Completed NA INTERVENTIONAL 2-arm NCT01223729

Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy

Sponsor: University of Catania

Conditions Minimal Hepatic Encephalopathy

Interventions Acetyl-L-Carnitine placebo

Updated 4 times since 2017 Last updated: Oct 18, 2010 Started: Apr 30, 2002 Completion: Nov 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01223729, this NA trial focuses on Minimal Hepatic Encephalopathy and remains completed. Sponsored by University of Catania, it has been updated 4 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Apr 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Catania

Data source: University of Catania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catania, Italy